• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体和孕激素受体阳性的甲状腺乳头状癌弥漫性硬化变异型:一例报告

Estrogen receptor- and progesterone receptor-positive diffuse sclerosing variant of papillary thyroid carcinoma: a case report.

作者信息

Kinoshita Yuichi, Takasu Kosho, Yuri Takashi, Yoshizawa Kastuhiko, Emoto Yuko, Tsubura Airo, Shikata Nobuaki

机构信息

Department of Pathology II, Kansai Medical University, Amagasaki, Japan ; Division of Diagnostic Cytopathology and Histopathology, Kansai Medical University Takii Hospital, Moriguchi, Amagasaki, Japan.

出版信息

Case Rep Oncol. 2013 Apr 6;6(1):216-23. doi: 10.1159/000350784. Print 2013 Jan.

DOI:10.1159/000350784
PMID:23626564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3636970/
Abstract

The diffuse sclerosing variant of papillary thyroid carcinoma (DSV-PTC) is a relatively rare tumor. We herein report the case of young woman with DSV-PTC who developed cervical lymph node recurrence 7 years after the initial surgery. A 15-year-old female patient with no medical or family history of thyroid tumors developed a thyroid neoplasm in the right lobe. Right thyroidectomy and regional lymphadenectomy were performed, and the tumor was diagnosed as DSV-PTC. She was followed up as an outpatient. Seven years after the surgery, cervical lymph node recurrence developed. On microscopic examination, the thyroid tumor showed a papillary growth pattern with numerous psammoma bodies and distinct fibrosis. Immunohistochemically, the tumor cells were estrogen receptor and progesterone receptor positive with reduced membranous expression of E-cadherin and were intermingled with S-100-positive dendritic/Langerhans cells. DSV-PTC is characterized by a strong tendency for invasion and metastasis. Thus, accurate diagnosis is clinically important, and a morphological and immunohistochemical understanding of DSV-PTC is necessary.

摘要

甲状腺乳头状癌弥漫硬化型(DSV-PTC)是一种相对罕见的肿瘤。我们在此报告一例患有DSV-PTC的年轻女性病例,该患者在初次手术后7年出现颈部淋巴结复发。一名15岁女性患者,无甲状腺肿瘤的个人或家族病史,其右叶出现甲状腺肿瘤。行右侧甲状腺切除术及区域淋巴结清扫术,肿瘤被诊断为DSV-PTC。她作为门诊患者接受随访。手术后7年,出现颈部淋巴结复发。显微镜检查显示,甲状腺肿瘤呈乳头状生长模式,有大量砂粒体和明显纤维化。免疫组化显示,肿瘤细胞雌激素受体和孕激素受体阳性,E-钙黏蛋白膜表达减少,并与S-100阳性树突状/朗格汉斯细胞混合。DSV-PTC的特点是具有很强的侵袭和转移倾向。因此,准确诊断在临床上很重要,对DSV-PTC进行形态学和免疫组化了解是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6e/3636970/901eaf6baaf6/cro-0006-0216-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6e/3636970/7215085f6512/cro-0006-0216-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6e/3636970/d44762f06a80/cro-0006-0216-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6e/3636970/7535967979a4/cro-0006-0216-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6e/3636970/901eaf6baaf6/cro-0006-0216-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6e/3636970/7215085f6512/cro-0006-0216-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6e/3636970/d44762f06a80/cro-0006-0216-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6e/3636970/7535967979a4/cro-0006-0216-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6e/3636970/901eaf6baaf6/cro-0006-0216-g04.jpg

相似文献

1
Estrogen receptor- and progesterone receptor-positive diffuse sclerosing variant of papillary thyroid carcinoma: a case report.雌激素受体和孕激素受体阳性的甲状腺乳头状癌弥漫性硬化变异型:一例报告
Case Rep Oncol. 2013 Apr 6;6(1):216-23. doi: 10.1159/000350784. Print 2013 Jan.
2
Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.甲状腺乳头状癌弥漫性硬化型:22例临床病理及免疫表型分析
Endocr Pathol. 2005 Winter;16(4):331-48. doi: 10.1385/ep:16:4:331.
3
Diffuse intrathyroidal dissemination of papillary thyroid carcinoma with no stromal fibrosis at presentation: A pattern of aggressive differentiated thyroid carcinoma.表现为无间质纤维化的甲状腺内播散性甲状腺乳头状癌:一种侵袭性分化型甲状腺癌模式。
Pathol Res Pract. 2021 Aug;224:153510. doi: 10.1016/j.prp.2021.153510. Epub 2021 Jun 23.
4
Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.甲状腺乳头状癌弥漫硬化型患者的临床病理特征及预后
World J Surg. 2015 Jul;39(7):1728-35. doi: 10.1007/s00268-015-3021-9.
5
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease.甲状腺腺癌中 KIF5B/RET 重排:一种致命疾病的病例报告。
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3091-3096. doi: 10.1210/jc.2017-00304.
6
Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.经典型乳头状甲状腺癌及其弥漫性硬化变体中E-钙黏蛋白/连环蛋白黏附复合体的异常。
J Pathol. 2001 Jul;194(3):358-66. doi: 10.1002/path.905.
7
Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion.在弥漫硬化型甲状腺乳头状癌中诱饵受体 3 的表达:与 M2 巨噬细胞分化和淋巴侵袭的相关性。
Thyroid. 2013 Jun;23(6):720-6. doi: 10.1089/thy.2012.0261. Epub 2013 May 28.
8
Axillary lymph node metastasis from papillary thyroid carcinoma with elevated CA 19-9 and CA 242 levels: a case report and literature review.伴有CA 19-9和CA 242水平升高的甲状腺乳头状癌腋窝淋巴结转移:1例报告并文献复习
Gland Surg. 2021 Mar;10(3):1147-1153. doi: 10.21037/gs-20-815.
9
Clinical Outcomes of Diffuse Sclerosing Variant Papillary Thyroid Carcinoma in Pediatric Patients.儿童弥漫硬化型甲状腺乳头状癌的临床转归。
Laryngoscope. 2022 May;132(5):1132-1138. doi: 10.1002/lary.29926. Epub 2021 Oct 29.
10
Relationship between recurrence and age in the diffuse sclerosing variant of papillary thyroid carcinoma: clinical significance in pediatric patients.弥漫硬化型甲状腺乳头状癌中复发与年龄的关系:儿科患者的临床意义。
Front Endocrinol (Lausanne). 2024 Jun 20;15:1359875. doi: 10.3389/fendo.2024.1359875. eCollection 2024.

引用本文的文献

1
Construction and validation of a nomogram for predicting cervical lymph node metastasis in diffuse sclerosing variant of papillary thyroid carcinoma.构建并验证用于预测弥漫硬化型甲状腺乳头状癌颈部淋巴结转移的列线图。
Langenbecks Arch Surg. 2023 Dec 14;409(1):8. doi: 10.1007/s00423-023-03178-8.
2
and expression in papillary thyroid cancer.以及在甲状腺乳头状癌中的表达。
Oncol Lett. 2021 May;21(5):342. doi: 10.3892/ol.2021.12603. Epub 2021 Mar 2.
3
EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.

本文引用的文献

1
Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk.雌激素和雄激素受体在分化型甲状腺癌中的表达:评估患者风险的附加标准。
Endocr Relat Cancer. 2012 Jun 18;19(4):463-71. doi: 10.1530/ERC-11-0389. Print 2012 Aug.
2
Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma.弥漫硬化型甲状腺乳头状癌的免疫组化特点:与经典型甲状腺乳头状癌的比较。
APMIS. 2010 Oct;118(10):744-52. doi: 10.1111/j.1600-0463.2010.02653.x.
3
The histopathology analysis of the diffuse sclerosing variant of the papillary carcinoma of the thyroid: a distinctive and rare form.
雌激素受体 α 上调 EZH2 诱导甲状腺乳头状癌的增殖和迁移。
BMC Cancer. 2019 Nov 12;19(1):1094. doi: 10.1186/s12885-019-6306-9.
4
Expression of estrogen and progesterone receptors in papillary thyroid carcinoma.雌激素和孕激素受体在甲状腺乳头状癌中的表达
Caspian J Intern Med. 2016 Summer;7(3):183-187.
甲状腺乳头状癌弥漫性硬化变异型的组织病理学分析:一种独特且罕见的类型。
Rom J Morphol Embryol. 2009;50(4):743-8.
4
Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young.弥漫硬化型是青年型甲状腺乳头状癌的主要亚型之一。
Thyroid. 2009 Nov;19(11):1225-31. doi: 10.1089/thy.2009.0073.
5
Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer.雌激素受体、孕激素受体及血管内皮生长因子-A在甲状腺癌中的表达
Am Surg. 2009 Sep;75(9):785-9; discussion 789.
6
Fine-needle aspiration of the diffuse sclerosing variant of papillary thyroid carcinoma masked by florid lymphocytic thyroiditis; A potential pitfall: A case report and review of the literature.
Diagn Cytopathol. 2009 Sep;37(9):671-5. doi: 10.1002/dc.21091.
7
Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution.日本甲状腺乳头状癌弥漫性硬化型的临床病理特征及预后:单机构18年经验
World J Surg. 2009 May;33(5):958-62. doi: 10.1007/s00268-009-9940-6.
8
Diffuse sclerosing variant of papillary carcinoma of the thyroid: imaging and cytologic findings.甲状腺乳头状癌的弥漫性硬化变异型:影像学及细胞学表现
Thyroid. 2007 Jun;17(6):567-73. doi: 10.1089/thy.2006.0321.
9
Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.甲状腺乳头状癌弥漫性硬化型:22例临床病理及免疫表型分析
Endocr Pathol. 2005 Winter;16(4):331-48. doi: 10.1385/ep:16:4:331.
10
Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution.甲状腺乳头状癌的弥漫性硬化变异型:在单一机构进行的35年比较研究。
Ann Surg Oncol. 2006 Feb;13(2):176-81. doi: 10.1245/ASO.2006.03.062. Epub 2006 Jan 17.